Titterton Lewis H jr
SEC Form 4 insider trading activity
Titterton Lewis H jr has filed 8 SEC Form 4 filings (9 transaction rows) across 2 companies, including ANIX, PRKR, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 25, 2026.
On the most recent filing, Titterton Lewis H jr is listed as Director at Anixa Biosciences Inc. Inside the rolling window, Titterton Lewis H jr reported 6 open-market purchases totaling $1.2M in ANIX and PRKR and no open-market sales. The largest disclosed transaction in the window is a purchase of 4,761,905 PRKR shares on Nov 18, 2025, worth $1.0M.
Companies traded
Other insiders at ANIX
Insider Buying
$1.2M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Titterton Lewis H jr made?
Titterton Lewis H jr has filed 8 SEC Form 4 filings (9 transaction rows) across 2 companies, including ANIX, PRKR since 2025.
Which companies does Titterton Lewis H jr trade?
Titterton Lewis H jr has filed SEC Form 4 disclosures for 2 companies, including ANIX, PRKR.
When was Titterton Lewis H jr's most recent SEC Form 4 filing?
Titterton Lewis H jr's most recent SEC Form 4 filing on Tracefour is dated Sep 25, 2026.
What is Titterton Lewis H jr's total buy and sell value in the current window?
Inside the rolling retention window, Titterton Lewis H jr bought $1.2M and sold $0 based on SEC Form 4 filings.
What was Titterton Lewis H jr's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 4,761,905 PRKR shares on 2025-11-18, worth $1.0M, per SEC Form 4 filings.